News

12 13 The transient transfection methods used for lentiviral vectors pose unique challenges for titering as they often lead to contamination of vector supernatants with plasmid DNA. Current ...
Feasibility study of a personalized tumor membrane vesicle vaccine immunotherapy for head and neck squamous cell carcinoma (HNSCC). This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I ...
The modified vector expressed the IL2RG complementary DNA from the eukaryotic human elongation factor 1α short promoter, which directs ubiquitous expression in mammalian cells, and has previously ...
This partnership aims to advance personalized cell therapy development by combining CellFE's Ryva™ Mechanoporation System with TcellTech's innovative nanoSMAR gene expression DNA vector platform.
CORALVILLE, Iowa (March 27, 2024)—Global genomics solutions provider Integrated DNA Technologies (IDT) is expanding its gene synthesis offerings with a new custom vector onboarding tool. The ...
The cell and gene therapy space has exploded in the last few years, and, as a result, Touchlight has seen demand spike for its synthetic DNA vector dbDNA. The latest fundraising round ...